Beaumont Health

Beaumont Health Scholarly Works and Archives
Conference Presentation Abstracts

Radiation Oncology

4-30-2022

MRI-based Synthetic CT images for IMPT Treatment Planning of
Nasopharyngeal Carcinoma Patients
S Chen
Y Peng
Y Liu
C Zhao
X Deng

See next page for additional authors

Follow this and additional works at: https://scholarlyworks.beaumont.org/
radiation_oncology_confabstract
Part of the Radiation Medicine Commons

Authors
S Chen, Y Peng, Y Liu, C Zhao, X Deng, A Qin, D Yan, C Stevens, R Deraniyagala, and X Ding

S1281

Abstract book

ESTRO 2022

reduced range uncertainty was evaluated for OARs and ring structures of various thickness (from 1mm to 20mm) surrounding
the CTV. Comparisons were made by evaluating mean and max dose to OARs and ring structures.
Results
The results show that reducing the range uncertainty in the treatment plan gives a slight reduction in nominal dose to the
surrounding tissue. Mean dose to brain outside CTV (Brain-CTV) is on average reduced by 3.4%(std=0.2%) over the ten
patients when reducing range uncertainty from 3.5% to 2%. Dose to the ring structure of 10mm surrounding the CTV was
reduced by 2% on average. In the worst-case scenarios for Brainstem and Chiasm, reducing the range from 3.5% to 2.0%
results in a reduction in max dose by 4.1% (0.7Gy) and 4.7% (1.5Gy) respectively. Table 1 contains the average dose
differences for the evaluated OARs.

Conclusion
Reducing the range uncertainty leads to meaningful reductions in dose to OARs. Whether the reduction is clinically relevant
or not needs to be seen in a context; if the dose to OARs is close to the dose constraints maximum, the reductions shown
in this study are very relevant. To obtain a relevant dose reduction of 2% in the mean dose to the brain outside CTV, new
modalities such as DECT needs to ensure that the range uncertainty can be reduced down to 2-2.5%.
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Purpose or Objective
To investigate the feasibility of using an MRI-based synthetic CT image (SCT) generated via a generative adversarial network
(GAN) for intensity-modulated proton therapy (IMPT) treatment planning of nasopharyngeal carcinoma (NPC) patients.
Materials and Methods
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T1-weighted MR images and paired CT (PCT) images were obtained from 158 NPC patients with radiotherapy immobilization.
Deformable image registration was performed between each MR and PCT image for each patient to create an MR-CT pair.
Thirteen pairs were randomly chosen as independent test sets and the remaining 145 pairs (10 for validation and 135 for
training) were used to build a conditional GAN model, including a residual-Unet as a generator and a 6-layer convolution
neural network as a discriminator. For each test patient, SCT was generated using the generator with the MR image as
input. A 4-beam IMPT plan was created and optimized on the corresponding PCT, and the dose matrix was recalculated on
the SCT. The dosimetric accuracy was evaluated by using the clinically relevant dose-volume histogram (DVH) parameters
and 3D gamma index analysis.
Results
The mean absolute error between the PCT and SCT images were (89.64+20.54)HU within the body. Figure 1 shows the MR,
PCT, SCT, and HU errors for a patient with an average performance of CT number accuracy. The DVH parameters
discrepancy between dose matrices calculated on PCT and SCT were (0.13+0.13)%, (0.4+0.44)%, (0.81+0.78)%, (1.25+1.26)%,
(1.24+0.78)%, and (1.35+1.1)% for CTV1-D95, CTV2-D95 (involved nodes), Left-parotid mean dose, right-parotid mean dose,
brain stem D1, and spinal cord D1, respectively. Figure 2 shows the dose matrices calculated on the PCT and SCT as well
as the DVH of critical structures and targets for a patient with an average performance of dosimetric accuracy. The 3%/3mm
(10% threshold) gamma passing rate was (97.26+2.35)% within the head and neck region for the 13 test patients.

Figure 1 (Left to right) MR, paired CT (PCT) and synthetic CT (SCT) as well as the HU error for a patient with an average
performance of CT number accuracy (mean absolute error = 86.66 HU).

Figure 2 Dose matrices calculated on paired CT (PCT) (top left) and synthetic CT (SCT) (top right) as well as the dosevolume histogram (bottom) (solid line: PCT and dashed line: SCT) for a patient with average performance of dosimetry
accuracy (3%/3mm gamma passing rate = 97.7%)
Conclusion
Overall, the SCT generated from MRI using GAN model achieved clinical acceptable dosimetric accuracy of IMPT planning
for NPC patients. However, further study is needed to validate the SCT algorithm on a larger patient cohort before clinical
implementations.
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Purpose or Objective
To fully exploit the benefits of proton therapy, an accurate stopping power ratio (SPR) prediction is necessary. In this study,
we evaluated the dose differences between robustly optimized proton plans based on single-energy CT (SECT) and dualenergy CT (DECT) for neuro-oncological patients.
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